Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
3(60%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
1
20%
Ph phase_1
1
20%
Ph early_phase_1
2
40%

Phase Distribution

3

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution4 total trials
Early Phase 1First-in-human
2(50.0%)
Phase 1Safety & dosage
1(25.0%)
N/ANon-phased studies
1(25.0%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

3

trials recruiting

Total Trials

5

all time

Status Distribution
Active(3)
Completed(1)
Other(1)

Detailed Status

Recruiting2
Active, not recruiting1
unknown1
Completed1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
3
Success Rate
100.0%
Most Advanced
Early Phase 1

Trials by Phase

Early Phase 12 (50.0%)
Phase 11 (25.0%)
N/A1 (25.0%)

Trials by Status

recruiting240%
active_not_recruiting120%
unknown120%
completed120%

Recent Activity

Clinical Trials (5)

Drug Details

Intervention Type
PROCEDURE
Total Trials
5